These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8077413)

  • 41. Group B rotavirus VP2: sequence analysis, expression, and gene coding assignment.
    Lindsay DA; Vonderfecht SL; Eiden JJ
    Virology; 1994 Feb; 199(1):141-50. PubMed ID: 8116237
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7sc.
    Both GW; Lockett LJ; Janardhana V; Edwards SJ; Bellamy AR; Graham FL; Prevec L; Andrew ME
    Virology; 1993 Apr; 193(2):940-50. PubMed ID: 8384761
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Purification of the IDIR strain of group B rotavirus and identification of viral structural proteins.
    Vonderfecht SL; Schemmer JK
    Virology; 1993 May; 194(1):277-83. PubMed ID: 8386876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
    Siadat-Pajouh M; Cai L
    Viral Immunol; 2001; 14(1):31-47. PubMed ID: 11270595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-VP6 IgG antibodies against group A and group C rotaviruses in South India.
    Mukhopadhya I; Anbu D; Iturriza-Gomara M; Gray JJ; Brown DW; Kavanagh O; Estes MK; Kang G
    Epidemiol Infect; 2010 Mar; 138(3):442-7. PubMed ID: 19723364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biochemical and immunological characterization of a novel peptide carrier system using rotavirus VP6 particles.
    Frenchick PJ; Sabara MI; Ready KF; Babiuk LA
    Vaccine; 1992; 10(11):783-91. PubMed ID: 1332271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mapping the subgroup epitopes of rotavirus protein VP6.
    López S; Espinosa R; Greenberg HB; Arias CF
    Virology; 1994 Oct; 204(1):153-62. PubMed ID: 7522369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants.
    Clements-Mann ML; Dudas R; Hoshino Y; Nehring P; Sperber E; Wagner M; Stephens I; Karron R; Deforest A; Kapikian AZ
    Vaccine; 2001 Sep; 19(32):4676-84. PubMed ID: 11535316
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NSP4 antibody levels in rotavirus gastroenteritis patients with seizures.
    Yeom JS; Kim YS; Jun JS; Do HJ; Park JS; Seo JH; Park ES; Lim JY; Woo HO; Park CH; Youn HS
    Eur J Paediatr Neurol; 2017 Mar; 21(2):367-373. PubMed ID: 27847298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peptide-Recombinant VP6 Protein Based Enzyme Immunoassay for the Detection of Group A Rotaviruses in Multiple Host Species.
    Kumar N; Malik YS; Kumar S; Sharma K; Sircar S; Saurabh S; Gulati BR; Singh N; Singh AK; Joshi VG; Banyai K; Dhama K
    PLoS One; 2016; 11(7):e0159027. PubMed ID: 27391106
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Homotypic and heterotypic serum neutralizing antibody response to rotavirus proteins following natural primary infection and reinfection in children.
    Gorrell RJ; Bishop RF
    J Med Virol; 1999 Feb; 57(2):204-11. PubMed ID: 9892409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polypeptide specificity of antiviral serum antibodies in children naturally infected with human rotavirus.
    Brüssow H; Offit PA; Gerna G; Bruttin A; Sidoti J
    J Virol; 1990 Sep; 64(9):4130-6. PubMed ID: 2166808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Self-assembling Rotavirus VP6 Nanoparticle Vaccines Expressed in Escherichia coli Elicit Systemic and Mucosal Responses in Mice.
    Li Z; Cui K; Huang K; Liu F; Shi D; Liu Q
    Protein Pept Lett; 2019; 26(12):904-909. PubMed ID: 31429685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting of rotavirus VP6 to DEC-205 induces protection against the infection in mice.
    Badillo-Godinez O; Gutierrez-Xicotencatl L; Plett-Torres T; Pedroza-Saavedra A; Gonzalez-Jaimes A; Chihu-Amparan L; Maldonado-Gama M; Espino-Solis G; Bonifaz LC; Esquivel-Guadarrama F
    Vaccine; 2015 Aug; 33(35):4228-37. PubMed ID: 25850020
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Replication as a determinant of the intestinal response to rotavirus.
    Shaw RD; Hempson SJ
    J Infect Dis; 1996 Dec; 174(6):1328-31. PubMed ID: 8940227
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A fusion protein of rotavirus VP6 and cholera toxin B subunit: expression in Escherichia coli and analysis of biological activities].
    Guo TX; Fang RX; Li GH; Qian Y
    Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):621-5. PubMed ID: 11910752
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reactivity of monoclonal antibodies to the 41-kilodalton protein of porcine group C rotavirus with homologous and heterologous rotavirus serogroups in immunofluorescence tests.
    Ojeh CK; Jiang BM; Tsunemitsu H; Kang SY; Weilnau PA; Saif LJ
    J Clin Microbiol; 1991 Sep; 29(9):2051-5. PubMed ID: 1663522
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential.
    Redmond MJ; Ijaz MK; Parker MD; Sabara MI; Dent D; Gibbons E; Babiuk LA
    Vaccine; 1993; 11(2):273-81. PubMed ID: 8382422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice.
    Garaicoechea L; Olichon A; Marcoppido G; Wigdorovitz A; Mozgovoj M; Saif L; Surrey T; Parreño V
    J Virol; 2008 Oct; 82(19):9753-64. PubMed ID: 18632867
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses.
    Choi AH; McNeal MM; Basu M; Flint JA; Stone SC; Clements JD; Bean JA; Poe SA; VanCott JL; Ward RL
    Vaccine; 2002 Sep; 20(27-28):3310-21. PubMed ID: 12213401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.